Literature DB >> 27579723

[Systemic therapy of breast cancer: practice guideline].

Zsolt Horváth1, Katalin Boér2, Magdolna Dank3, Zsuzsanna Kahán4, Judit Kocsis1, Erika Kövér5, Gábor Pajkos6, Béla Pikó7, Gábor Rubovszky8, Sándor Eckhardt9.   

Abstract

The article presents the practice guideline of systemic treatment of breast cancer and recommendations of the 3rd Hungarian Breast Cancer Consensus Conference. It reflects the recent international guidelines (ESMO, NCCN, ABC2, St Gallen's) irrespectively of the current financial opportunities. Here we follow the early - locally advanced - locally relapsed - metastatic breast cancer line for didactic considerations and we discuss the different subgroups of breast cancer based on hormone receptor and HER2 receptor status. Diagnosis and treatment options of rare clinical entities are summarised at the end of the paper.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27579723

Source DB:  PubMed          Journal:  Magy Onkol        ISSN: 0025-0244


  3 in total

1.  Synchronous papillary thyroid carcinoma and breast ductal carcinoma: A rare case report and literature review.

Authors:  Jinjing Zhong; Jianyong Lei; Ke Jiang; Zhihui Li; Rixiang Gong; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

2.  Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Authors:  Gábor Rubovszky; Judit Kocsis; Katalin Boér; Nataliya Chilingirova; Magdolna Dank; Zsuzsanna Kahán; Dilyara Kaidarova; Erika Kövér; Bibiana Vertáková Krakovská; Károly Máhr; Bela Mriňáková; Béla Pikó; Ivana Božović-Spasojević; Zsolt Horváth
Journal:  Pathol Oncol Res       Date:  2022-07-11       Impact factor: 2.874

3.  Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.

Authors:  Katalin Boér; Zsuzsanna Kahán; László Landherr; Tibor Csőszi; Károly Máhr; Ágnes Ruzsa; Zsolt Horváth; Barna Budai; Gábor Rubovszky
Journal:  Pathol Oncol Res       Date:  2021-05-04       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.